Literature DB >> 26779454

Neuropsychiatric Symptoms in Dementia: Overview and Measurement Challenges.

C G Lyketsos1.   

Abstract

Entities:  

Year:  2015        PMID： 26779454      PMCID： PMC4712963          DOI： 10.14283/jpad.2015.60

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN： 2274-5807


× No keyword cloud information.
  14 in total

1.  Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients.

Authors:  Fernando E Taragano; Ricardo F Allegri; Hugo Krupitzki; Diego R Sarasola; Cecilia M Serrano; Leandro Loñ; Constantine G Lyketsos
Journal:  J Clin Psychiatry       Date:  2009-03-24       Impact factor: 4.384

2.  Neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Constantine G Lyketsos; Maria C Carrillo; J Michael Ryan; Ara S Khachaturian; Paula Trzepacz; Joan Amatniek; Jesse Cedarbaum; Robert Brashear; David S Miller
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

Review 3.  Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

4.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

5.  Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study.

Authors:  Paul B Rosenberg; Michelle M Mielke; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2005-09       Impact factor: 4.105

6.  Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.

Authors:  Lawrence S Mayer; R Curt Bay; Antonios Politis; Martin Steinberg; Cynthia Steele; Alva S Baker; Peter V Rabins; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2006-10       Impact factor: 3.485

7.  Provisional diagnostic criteria for depression of Alzheimer disease.

Authors:  Jason T Olin; Lon S Schneider; Ira R Katz; Barnett S Meyers; George S Alexopoulos; John C Breitner; Martha L Bruce; Eric D Caine; Jeffrey L Cummings; Davangere P Devanand; K Ranga Rama Krishnan; Constantine G Lyketsos; Jeffrey M Lyness; Peter V Rabins; Charles F Reynolds; Barry W Rovner; David C Steffens; Pierre N Tariot; Barry D Lebowitz
Journal:  Am J Geriatr Psychiatry       Date:  2002 Mar-Apr       Impact factor: 4.105

8.  Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

Authors:  Constantine G Lyketsos; Oscar Lopez; Beverly Jones; Annette L Fitzpatrick; John Breitner; Steven DeKosky
Journal:  JAMA       Date:  2002-09-25       Impact factor: 56.272

9.  Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders.

Authors:  P Robert; C U Onyike; A F G Leentjens; K Dujardin; P Aalten; S Starkstein; F R J Verhey; J Yessavage; J P Clement; D Drapier; F Bayle; M Benoit; P Boyer; P M Lorca; F Thibaut; S Gauthier; G Grossberg; B Vellas; J Byrne
Journal:  Eur Psychiatry       Date:  2009-02-07       Impact factor: 5.361

10.  Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study.

Authors:  Martin Steinberg; Huibo Shao; Peter Zandi; Constantine G Lyketsos; Kathleen A Welsh-Bohmer; Maria C Norton; John C S Breitner; David C Steffens; Joann T Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2008-02       Impact factor: 3.485
View more
  9 in total

1.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Authors:  Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

2.  Nomenclature Used by Family Caregivers to Describe and Characterize Neuropsychiatric Symptoms.

Authors:  Andrea Gilmore-Bykovskyi; Shannon Mullen; Laura Block; Abigail Jacobs; Nicole E Werner
Journal:  Gerontologist       Date:  2020-07-15

3.  How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment.

Authors:  Ariel R Green; Jennifer L Wolff; Diane M Echavarria; Malcolm Chapman; Annie Phung; Devon Smith; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

4.  Shared genetic etiology underlying late-onset Alzheimer's disease and posttraumatic stress syndrome.

Authors:  Michael W Lutz; Sheng Luo; Douglas E Williamson; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2020-06-26       Impact factor: 21.566

5.  Information and Communication Technologies, a Promising Way to Support Pharmacotherapy for the Behavioral and Psychological Symptoms of Dementia.

Authors:  Antoine Piau; Pierre Rumeau; Fati Nourhashemi; Maria Soto Martin
Journal:  Front Pharmacol       Date:  2019-09-30       Impact factor: 5.810

6.  Polygenic Risk Score Effectively Predicts Depression Onset in Alzheimer's Disease Based on Major Depressive Disorder Risk Variants.

Authors:  Suraj Upadhya; Hongliang Liu; Sheng Luo; Michael W Lutz; Ornit Chiba-Falek
Journal:  Front Neurosci       Date:  2022-03-08       Impact factor: 4.677

7.  Psychiatric and Psychosocial Characteristics of a Cohort of Spanish Individuals Attending Genetic Counseling Due to Risk for Genetically Conditioned Dementia.

Authors:  Pau Sobregrau; Josep M Peri; Raquel Sánchez Del Valle; Jose L Molinuevo; Bernardo Barra; Luís Pintor
Journal:  J Alzheimers Dis Rep       Date:  2022-08-05

8.  Shared genetic etiology underlying Alzheimer's disease and major depressive disorder.

Authors:  Michael W Lutz; Daniel Sprague; Julio Barrera; Ornit Chiba-Falek
Journal:  Transl Psychiatry       Date:  2020-03-09       Impact factor: 6.222

9.  Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review.

Authors:  Florindo Stella; Leandro C Lane Valiengo; Vanessa J R de Paula; Carlos Augusto de Mendonça Lima; Orestes V Forlenza
Journal:  Trends Psychiatry Psychother       Date:  2021-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.